(KMB) Kimberly-Clark - Ratings and Ratios
Diapers, Wipes, Tissue, Towels, Sanitizers
KMB EPS (Earnings per Share)
KMB Revenue
Description: KMB Kimberly-Clark September 29, 2025
Kimberly-Clark Corp. (KMB) manufactures and markets a broad portfolio of personal-care and tissue products from its Dallas headquarters, operating through three geographic-segment lines: North America, International Personal Care, and International Family Care & Professional.
In North America, the company sells disposable diapers, training pants, baby wipes, feminine- and incontinence-care items, as well as facial and bathroom tissue, paper towels, napkins, soaps and sanitizers under brands such as Huggies, Pull-Ups, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle and Viva. The International Personal Care segment mirrors the North-American baby- and adult-care lineup (e.g., Huggies, Kotex, Goodfeel, Depend) for markets outside the U.S., while the International Family Care & Professional segment focuses on tissue, towel and cleaning solutions for households and commercial users under Kleenex, Scott, Viva, Andrex, Scottex and Wypall.
Distribution channels span supermarkets, mass merchandisers, drugstores, warehouse clubs, e-commerce platforms, and direct-to-business channels serving hotels, food-service and public facilities.
Key recent metrics (FY 2023): net sales of $19.5 billion, operating cash flow of $2.5 billion, and a dividend yield around 3.5 % with a 10-year payout consistency record. The stock trades at a forward P/E of roughly 14×, reflecting the sector’s defensive positioning and modest growth expectations.
Economic drivers that materially affect KMB include consumer-price inflation (which pressures input costs but also enables price-pass-through in essential categories), the shift toward e-commerce and direct-to-consumer channels, and sustainability trends that are prompting product-line innovations such as recycled-content tissue and biodegradable wipes.
For a deeper, data-driven valuation framework, you might explore the KMB profile on ValueRay.
KMB Stock Overview
| Market Cap in USD | 39,898m |
| Sub-Industry | Household Products |
| IPO / Inception | 1984-12-17 |
KMB Stock Ratings
| Growth Rating | -12.6% |
| Fundamental | 65.3% |
| Dividend Rating | 53.0% |
| Return 12m vs S&P 500 | -34.9% |
| Analyst Rating | 3.26 of 5 |
KMB Dividends
| Dividend Yield 12m | 4.89% |
| Yield on Cost 5y | 4.45% |
| Annual Growth 5y | 3.33% |
| Payout Consistency | 54.4% |
| Payout Ratio | 72.7% |
KMB Growth Ratios
| Growth Correlation 3m | -95.1% |
| Growth Correlation 12m | -31% |
| Growth Correlation 5y | 65.2% |
| CAGR 5y | -3.42% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.11 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.42 |
| Sharpe Ratio 12m | -0.57 |
| Alpha | -31.27 |
| Beta | 0.306 |
| Volatility | 83.26% |
| Current Volume | 15948.8k |
| Average Volume 20d | 2337.2k |
| Stop Loss | 97.6 (-3%) |
| Signal | -1.34 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (1.97b TTM) > 0 and > 6% of Revenue (6% = 1.08b TTM) |
| FCFTA 0.14 (>2.0%) and ΔFCFTA -2.62pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -8.87% (prev -6.06%; Δ -2.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 2.62b > Net Income 1.97b (YES >=105%, WARN >=100%) |
| Net Debt (5.85b) to EBITDA (3.26b) ratio: 1.80 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (333.3m) change vs 12m ago -1.16% (target <= -2.0% for YES) |
| Gross Margin 35.10% (prev 36.03%; Δ -0.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 106.1% (prev 117.1%; Δ -11.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.33 (EBITDA TTM 3.26b / Interest Expense TTM 260.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.61
| (A) -0.09 = (Total Current Assets 5.47b - Total Current Liabilities 7.08b) / Total Assets 16.89b |
| (B) 0.56 = Retained Earnings (Balance) 9.52b / Total Assets 16.89b |
| (C) 0.14 = EBIT TTM 2.43b / Avg Total Assets 17.03b |
| (D) 0.42 = Book Value of Equity 6.50b / Total Liabilities 15.56b |
| Total Rating: 2.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.28
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 5.27% = 2.64 |
| 3. FCF Margin 13.36% = 3.34 |
| 4. Debt/Equity 4.86 = -2.49 |
| 5. Debt/Ebitda 1.80 = 0.40 |
| 6. ROIC - WACC (= 10.60)% = 12.50 |
| 7. RoE 173.3% = 2.50 |
| 8. Rev. Trend -75.47% = -5.66 |
| 9. EPS Trend 31.13% = 1.56 |
What is the price of KMB shares?
Over the past week, the price has changed by -16.59%, over one month by -16.51%, over three months by -23.67% and over the past year by -21.92%.
Is Kimberly-Clark a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KMB is around 87.41 USD . This means that KMB is currently overvalued and has a potential downside of -13.15%.
Is KMB a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 12
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the KMB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 137.2 | 36.3% |
| Analysts Target Price | 137.2 | 36.3% |
| ValueRay Target Price | 95.5 | -5.1% |
KMB Fundamental Data Overview November 02, 2025
P/E Trailing = 20.2555
P/E Forward = 15.4799
P/S = 2.0228
P/B = 32.0085
P/EG = 4.8401
Beta = 0.306
Revenue TTM = 18.06b USD
EBIT TTM = 2.43b USD
EBITDA TTM = 3.26b USD
Long Term Debt = 6.88b USD (from longTermDebt, last fiscal year)
Short Term Debt = 683.0m USD (from shortTermDebt, last fiscal year)
Debt = 6.47b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.85b USD (from netDebt column, last quarter)
Enterprise Value = 45.75b USD (39.90b + Debt 6.47b - CCE 617.0m)
Interest Coverage Ratio = 9.33 (Ebit TTM 2.43b / Interest Expense TTM 260.0m)
FCF Yield = 5.27% (FCF TTM 2.41b / Enterprise Value 45.75b)
FCF Margin = 13.36% (FCF TTM 2.41b / Revenue TTM 18.06b)
Net Margin = 10.90% (Net Income TTM 1.97b / Revenue TTM 18.06b)
Gross Margin = 35.10% ((Revenue TTM 18.06b - Cost of Revenue TTM 11.72b) / Revenue TTM)
Gross Margin QoQ = 35.71% (prev 34.97%)
Tobins Q-Ratio = 2.71 (Enterprise Value 45.75b / Total Assets 16.89b)
Interest Expense / Debt = 1.00% (Interest Expense 65.0m / Debt 6.47b)
Taxrate = 41.89% (248.0m / 592.0m)
NOPAT = 1.41b (EBIT 2.43b * (1 - 41.89%))
Current Ratio = 0.77 (Total Current Assets 5.47b / Total Current Liabilities 7.08b)
Debt / Equity = 4.86 (Debt 6.47b / totalStockholderEquity, last quarter 1.33b)
Debt / EBITDA = 1.80 (Net Debt 5.85b / EBITDA 3.26b)
Debt / FCF = 2.43 (Net Debt 5.85b / FCF TTM 2.41b)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.66% (Net Income 1.97b / Total Assets 16.89b)
RoE = 173.3% (Net Income TTM 1.97b / Total Stockholder Equity 1.14b)
RoCE = 30.30% (EBIT 2.43b / Capital Employed (Equity 1.14b + L.T.Debt 6.88b))
RoIC = 16.83% (NOPAT 1.41b / Invested Capital 8.38b)
WACC = 6.23% (E(39.90b)/V(46.37b) * Re(7.14%) + D(6.47b)/V(46.37b) * Rd(1.00%) * (1-Tc(0.42)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.84%
[DCF Debug] Terminal Value 79.74% ; FCFE base≈2.61b ; Y1≈2.90b ; Y5≈3.79b
Fair Price DCF = 198.2 (DCF Value 65.77b / Shares Outstanding 331.9m; 5y FCF grow 12.69% → 3.0% )
EPS Correlation: 31.13 | EPS CAGR: 6.26% | SUE: 0.48 | # QB: 0
Revenue Correlation: -75.47 | Revenue CAGR: -6.45% | SUE: 0.23 | # QB: 0
Additional Sources for KMB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle